Add to ORKGA new study reveals that the findings obtained from industry sponsored studies for widely prescribed cholesterol drugs are similar in magnitude as those in non-industry sources. Huseyin Naci, LSE Health research fellow and co-author of the study, explains further
INTRODUCTION AND AIMS: There have been no previous quantitative analyses of the possible effects of ...
Funding of research by industry in general can lead to sponsorship bias. The aim of the current stud...
An early research study found that a diabetes drug reduced cardiovascular events compared to a place...
OBJECTIVE: To explore the risk of industry sponsorship bias in a systematically identified set of pl...
Objective To explore the risk of industry sponsorship bias in a systematically identified set of pla...
Industry-sponsored clinical drug studies are associated with publication of outcomes that favor the ...
<div><p>Industry-sponsored clinical drug studies are associated with publication of outcomes that fa...
Abstract: We know that clinical trials sponsored by the pharmaceutical industry are likely to exagge...
Concerns about potentially misleading reporting of pharmaceutical industry research have surfaced ma...
Industry-sponsored clinical drug studies are associated with publication of outcomes that favor the ...
More than 40 primary studies, and three recent systematic reviews and meta-analyses, have shown a cl...
Published pharmaceutical industry–sponsored trials are more likely than non-industry-sponsored trial...
Introduction: There is little evidence regarding the influence of conflicts of interest on preclinic...
Industry-sponsored clinical drug studies are associated with publication of outcomes that favor the ...
Previous authors have suggested a higher likelihood for industry-sponsored (IS) studies to have posi...
INTRODUCTION AND AIMS: There have been no previous quantitative analyses of the possible effects of ...
Funding of research by industry in general can lead to sponsorship bias. The aim of the current stud...
An early research study found that a diabetes drug reduced cardiovascular events compared to a place...
OBJECTIVE: To explore the risk of industry sponsorship bias in a systematically identified set of pl...
Objective To explore the risk of industry sponsorship bias in a systematically identified set of pla...
Industry-sponsored clinical drug studies are associated with publication of outcomes that favor the ...
<div><p>Industry-sponsored clinical drug studies are associated with publication of outcomes that fa...
Abstract: We know that clinical trials sponsored by the pharmaceutical industry are likely to exagge...
Concerns about potentially misleading reporting of pharmaceutical industry research have surfaced ma...
Industry-sponsored clinical drug studies are associated with publication of outcomes that favor the ...
More than 40 primary studies, and three recent systematic reviews and meta-analyses, have shown a cl...
Published pharmaceutical industry–sponsored trials are more likely than non-industry-sponsored trial...
Introduction: There is little evidence regarding the influence of conflicts of interest on preclinic...
Industry-sponsored clinical drug studies are associated with publication of outcomes that favor the ...
Previous authors have suggested a higher likelihood for industry-sponsored (IS) studies to have posi...
INTRODUCTION AND AIMS: There have been no previous quantitative analyses of the possible effects of ...
Funding of research by industry in general can lead to sponsorship bias. The aim of the current stud...
An early research study found that a diabetes drug reduced cardiovascular events compared to a place...